UK Market Access · 2026 Updated

UKCA for Medical Devices — Your Complete Guide to UK Market Entry

The UKCA mark is the legal requirement to sell medical devices in Great Britain. Whether you’re a US manufacturer entering the UK market, or already CE-marked and planning your transition — TraccGlobal provides end-to-end UKCA mark certification support, MHRA registration, and UK Responsible Person services that get your device to market without delays.

200+ Global Certifications Delivered

98% First-Attempt Approval Rate

20+ Countries Served (incl. USA & UK)

48h Query Resolution SLA

Quick Answer: The UKCA (UK Conformity Assessed) mark is mandatory for medical devices sold in Great Britain (England, Scotland, Wales) after Brexit. It is governed by the UK MDR 2002, regulated by the MHRA, and requires MHRA registration + conformity assessment by a UK Approved Body for Class IIa and above. CE-marked devices are accepted under transitional rules until June 2028–2030, depending on device class. Class I non-sterile, non-measuring devices can self-certify. All non-UK manufacturers must appoint a UK Responsible Person (UKRP).

Definition & Background

What Is UKCA Marking for Medical Devices?

The UKCA mark (UK Conformity Assessed) is the official conformity marking required to legally sell medical devices in Great Britain — England, Scotland, and Wales. It was introduced after Brexit as the UK’s independent replacement for the EU CE mark, governed by the UK Medical Devices Regulations 2002 (UK MDR 2002) and enforced by the Medicines and Healthcare products Regulatory Agency (MHRA).

When a medical device carries the UKCA mark, it tells regulators, buyers, and healthcare providers that the device has been assessed, documented, and registered as meeting all essential safety and performance requirements under UK law. For US manufacturers and global exporters, the UKCA mark is your gateway to the Great Britain healthcare market — a market worth over £30 billion annually.

Unlike the CE mark, UKCA marking is not recognized in the EU. Similarly, CE marking alone (after transitional periods expire) will not be accepted in Great Britain. Northern Ireland follows different rules — it continues to require CE marking under the Windsor Framework and does not accept UKCA marking.

At TraccGlobal, we help manufacturers across the USA, Europe, and Asia navigate the UKCA certification pathway efficiently — reducing time-to-market and eliminating costly regulatory mistakes.

Where UKCA Mark Is Required

Where UKCA Is NOT Valid

Governing Framework

Side-by-Side Comparison

UKCA vs CE Marking for Medical Devices

Understanding how these two systems differ is critical for manufacturers selling in both the UK and EU markets — especially US companies planning dual-market entry.

Feature	UKCA Mark	CE Mark (EU)
Market Covered	Great Britain (England, Scotland, Wales)	EU Member States + EEA (Norway, Iceland, Liechtenstein)
Regulating Authority	MHRA (Medicines & Healthcare Products Regulatory Agency)	National Competent Authorities (e.g., BSI for UK, ANSM for France)
Governing Regulation	UK MDR 2002 (based on old EU Directives)	EU MDR 2017/745 & EU IVDR 2017/746
Conformity Body	UK Approved Body (designated by MHRA)	EU Notified Body (designated by EU member state)
Northern Ireland	Not recognized – CE / UKNI required	Required – CE or UKNI mark
Class I Self-Certification	Yes (non-sterile, non-measuring)	Yes (non-sterile, non-measuring, non-reusable surgical)
Registration System	MHRA DORS (Device Online Registration System)	EUDAMED (EU Database on Medical Devices)
Representative Required	UK Responsible Person (UKRP) for non-UK manufacturers	EU Authorised Representative for non-EU manufacturers
UDI Requirements	Not yet mandatory (planned with new UK MDR)	Mandatory under EU MDR/IVDR
Dual Marking	UKCA + CE dual marking permitted	CE + UKCA dual marking permitted
Mutual Recognition	UKCA not recognized in EU	CE not recognized in GB after transition ends

What Is Class 1, 2, 3 in Medical Devices? (UK Classification)

Under UK MDR 2002, medical devices are classified into risk-based classes. Your device class determines whether you need a UK Approved Body and how rigorous your technical documentation must be.

Class I — Low Risk

Class I Medical Devices

Lowest risk. These devices have minimal potential to harm patients. Simple, non-invasive, or passive devices. Includes Class Is (sterile) and Class Im (measuring) subclasses.

Examples: Bandages, tongue depressors, walking frames, non-measuring surgical instruments, cotton wool

UKCA: Self-certification (non-sterile, non-measuring). UK Approved Body

Route: required for sterile/measuring subclasses

Technical File: Required. Clinical evaluation mandatory.

Class IIa — Medium Risk

Class IIa Medical Devices

Medium risk. Typically used for short-term contact with the body or for diagnosis. UK Approved Body must review technical documentation and audit the quality management system.

Examples: Dental materials, diagnostic ultrasound, contact lenses, surgical gloves, short-term implants

UKCA Route: UK Approved Body required. QMS audit + technical file review

ISO 13485:Required for QMS certification

Class IIb — Higher Risk

Class IIb Medical Devices

Higher risk. Devices with longer-term or more significant systemic effects. Requires thorough UK Approved Body conformity assessment including full QMS audit or type examination.

Examples: Infusion pumps, ventilators, blood glucose monitors, long-term implants (non-Class III)

UKCA Route:UK Approved Body required. Full QMS audit or type examination

Clinical Data:Substantial clinical evidence required

Class III — Highest Risk

Class III Medical Devices

Highest risk classification. These devices interact with the central cardiovascular system, central nervous system, or are life-supporting. Most rigorous UKCA assessment including design dossier examination.

Examples: Pacemakers, coronary stents, total hip replacements, spinal disc cages, breast implants

UKCA Route:UK Approved Body + design dossier examination. Full QMS audit

CE Transition:Class III implantables accepted until December 2027

IVD Note: In vitro diagnostic (IVD) devices follow a separate list-based classification under Part IV of UK MDR 2002. Most general IVDs can self-certify. Annex II List A/B IVDs and self-test IVDs require UK Approved Body involvement. TraccGlobal has deep IVD registration expertise across diagnostic kits, analysers, and point-of-care devices.

Regulatory Timeline

UKCA Deadlines & Transition Periods (2024–2030)

The UK government has introduced phased transition timelines to allow manufacturers to adapt. Here’s what US manufacturers and global exporters need to know right now.

Pre-2021

Historical

Completed

CE Marking – Only Route to UK Market

Prior to Brexit, CE marking was the sole conformity requirement for all UK and EU markets.

Jan 2021

Post-Brexit

Completed

UKCA Mark Introduced

UKCA marking officially introduced for Great Britain. CE marking continued to be accepted during transition.

Jul 2024

Active

New Devices Must Be UKCA Certified

New medical devices entering the Great Britain market must have UKCA certification.

Mid-2026

Upcoming

New UK Medical Device Regulation

Updated UK MDR expected with MDR-aligned classification, UDI, and international reliance routes.

Jun 2028

Key Deadline

Plan Now

CE Mark Transition Ends for Class IIa/IIb Devices

CE-marked Class IIa, IIb, Im, and Is devices must transition to UKCA certification.

Jun 2030

Final Deadline

Plan Now

Full UKCA Compliance Required

All CE-marked medical devices must transition to UKCA certification by June 2030.

Specific Guidance for US Manufacturers

Already CE Marked? Here's Your UKCA Checklist

Step-by-Step Guide

How to Get UKCA Mark for Medical Devices — 7-Step Process

TraccGlobal manages the entire UKCA certification process on your behalf — from device classification to MHRA registration and ongoing post-market surveillance compliance.

Device Classification Under UK MDR 2002

Correctly classify your device as Class I, IIa, IIb, or III under UK MDR 2002 Annex IX rules. This determines your conformity route — whether you self-certify or need a UK Approved Body. Wrong classification is the #1 cause of regulatory delays. Our team reviews intended use, body interaction, invasiveness, and duration to confirm the correct class before any documentation work begins.

Appoint a UK Responsible Person (UKRP)

If your business is located outside the UK, you legally must appoint a UK Responsible Person based in Great Britain before registering with MHRA. The UKRP is your legal point of contact with MHRA, holds copies of your technical documentation and Declaration of Conformity, and is responsible for post-market vigilance reporting. TraccGlobal can act as your UKRP or coordinate the appointment through our UK network partners.

Technical Documentation Preparation

Prepare the complete technical file demonstrating that your device meets all essential requirements of UK MDR 2002. This is the most critical and time-intensive step. Incomplete or misaligned documentation is the primary reason MHRA raises queries or rejects applications. Our team prepares documentation that is thoroughly aligned to UK requirements — not just repurposed EU MDR files.

QMS Certification — ISO 13485

For Class IIa and above, your Quality Management System must be certified to ISO 13485:2016 by an accredited body. UKCA conformity assessment by the UK Approved Body includes a QMS audit. TraccGlobal helps manufacturers build, implement, and audit-ready their QMS — including gap assessment, SOPs, FMEA, and post-market surveillance procedures.

UK Approved Body Conformity Assessment

For Class I sterile/measuring, IIa, IIb, and III devices, a UK Approved Body (designated by MHRA) must review your technical documentation and conduct a QMS audit. They assess whether your device meets all essential requirements. If satisfied, they issue a UKCA Certificate of Conformity. TraccGlobal coordinates the entire UK Approved Body process — selecting the right body, preparing you for audit, and resolving any non-conformities raised.

UK Declaration of Conformity & Labelling

Once conformity assessment is complete, the manufacturer issues a UK Declaration of Conformity (DoC) — a legally binding statement that the device meets UK MDR 2002 requirements. The UKCA mark and (where applicable) the UK Approved Body 4-digit identification number must then be affixed visibly and legibly to the device, label, packaging, or accompanying documents.

MHRA Registration via DORS

All medical devices must be registered with MHRA via the DORS (Device Online Registration System) before being placed on the Great Britain market. TraccGlobal manages the entire MHRA registration on your behalf — account setup, device submission, conformity assessment detail entry, and fee payment. Once registered, your device is legally authorized for the UK market.

Real-World Experience · EEAT Verified

Real Case Studies — How TraccGlobal Has Delivered UK Market Access

These case studies reflect actual regulatory challenges and outcomes from TraccGlobal’s client engagements. Manufacturer names are kept confidential per NDA.

USA → UK · Class IIb

US Infusion Pump Manufacturer — UKCA Certification in 8 Months

A mid-sized US manufacturer of Class IIb infusion pumps needed UK market access alongside their existing FDA 510(k) clearance. Their technical file was prepared to US 21 CFR Part 820 standards, not UK MDR 2002 essential requirements. TraccGlobal's team reformatted the clinical evaluation, updated the biocompatibility section to ISO 10993, prepared the UK Declaration of Conformity, coordinated UK Approved Body audit, and managed MHRA DORS registration. The UKCA certificate was issued in 8 months — significantly faster than their initial estimate of 12–15 months.

UK market access achieved. Device now sold through 3 NHS trust procurement frameworks.

Germany → UK · Class III

German Orthopaedic Implant Maker — Dual CE + UKCA Certification

A German manufacturer of Class III spinal implants approached TraccGlobal when their existing EU Notified Body (BSI) transitioned to a UK Approved Body post-Brexit. They needed UKCA certification without disrupting their existing CE-marked supply chain. TraccGlobal coordinated simultaneous CE (EU MDR) and UKCA (UK MDR 2002) assessments, managed design dossier preparation for both pathways, and resolved 6 technical queries from the UK Approved Body. Dual certification was achieved in 11 months with zero supply chain disruption.

CE + UKCA dual-certified. Full UK + EU market access maintained throughout.

India → UK · IVD Diagnostic

Indian IVD Startup — UKCA + MHRA Registration for Blood Glucose System

A Bengaluru-based IVD startup developed a Class IIb blood glucose monitoring system and targeted the UK as their first export market. They had no prior UK regulatory experience and needed a UK Responsible Person as well as full UKCA certification. TraccGlobal acted as their UKRP, prepared the complete technical file from scratch (clinical performance evaluation per UK MDR 2002, risk management file, PMS plan), coordinated UK Approved Body assessment, and completed MHRA DORS registration in 9 months. The client secured a UK distribution agreement within 60 days of receiving their UKCA certificate.

UK distribution partnership signed. £2.1M first-year purchase order confirmed.

Risk Avoidance

6 Costly Mistakes That Delay Your UKCA Certification

These are the most common errors US and global manufacturers make when attempting UKCA certification without expert support.

Assuming FDA 510(k) Covers UK Market Access

FDA clearance does not grant any UK regulatory approval. UKCA is a completely separate process under a different regulatory framework (UK MDR 2002). Each market requires its own certification.

Repurposing EU MDR Technical Files Without Adaptation

UK MDR 2002 is based on old EU Directives, not the current EU MDR 2017/745. Simply submitting your EU MDR technical file for UKCA review will result in non-conformities and delays.

Not Appointing a UK Responsible Person Early

Non-UK manufacturers cannot register with MHRA or place devices on the GB market without a UKRP. Failing to appoint one before starting MHRA registration causes immediate rejection.

Choosing an EU Notified Body for UKCA Assessment

EU Notified Bodies cannot issue UKCA certificates. Only UK Approved Bodies (designated by MHRA) are authorized. Many EU bodies now operate UK subsidiaries — confirm the legal entity carefully.

Incorrect Device Classification Under UK Rules

Some devices classify differently under UK MDR 2002 versus EU MDR due to rule differences. Misclassification wastes months of documentation effort and may result in wrong conformity routes.

Missing the MHRA DORS Registration Before Marketing

Even with UKCA certification, devices cannot legally be placed on the GB market until registered in MHRA's Device Online Registration System (DORS). This is a separate mandatory step.

Why TraccGlobal

Why Manufacturers Choose TraccGlobal for UKCA Certification

We are not a generic consulting firm. TraccGlobal combines deep UKCA regulatory expertise, real UK network partnerships, and a proven track record with 200+ global device certifications.

Expert UKCA Classification Advisory

We correctly classify your device under UK MDR 2002 rules before any documentation work begins — preventing costly rework and rejection.

UK Responsible Person Services

TraccGlobal provides UKRP services through our UK partner network — your legal presence in Great Britain, handling MHRA correspondence and vigilance reporting.

UK-Aligned Technical Documentation

We prepare technical files specifically aligned to UK MDR 2002 essential requirements — not just adapted EU MDR files. This is the critical difference that avoids Approved Body non-conformities.

UK Approved Body Coordination

We coordinate the entire UK Approved Body process — selecting the right body for your device, preparing your team for audit, and resolving any non-conformities raised during assessment.

CE + UKCA Dual Certification Strategy

For manufacturers targeting both the EU and UK markets, we design an integrated dual-certification strategy that minimizes duplicated effort and documentation cost.

Post-Market Surveillance Support

UKCA certification is ongoing — not a one-time event. We provide PMS plan implementation, MHRA vigilance reporting, surveillance audit preparation, and certificate renewal support.

Frequently Asked Questions

UKCA Medical Device Certification — Full FAQ

Answers to the most-searched questions about UKCA mark medical devices, optimized for Google Featured Snippets and AI Overview.

What is the UKCA mark for medical devices?

The UKCA (UK Conformity Assessed) mark is the mandatory conformity marking for medical devices sold in Great Britain (England, Scotland, Wales). Introduced after Brexit, it operates under the UK Medical Devices Regulations 2002 (UK MDR 2002), enforced by the MHRA. The UKCA mark confirms a device meets UK essential safety requirements, has been registered with MHRA, and (for Class IIa and above) has been assessed by a UK Approved Body. It replaces CE marking as the route to the GB medical device market.

Is UKCA marking mandatory in 2026?

Yes, in 2026 UKCA marking requirements are actively in force. New devices entering the Great Britain market after July 2024 must be UKCA certified. However, CE-marked devices already on the market continue to be accepted under transitional arrangements until 2028 or 2030 depending on device class. Additionally, the new UK Medical Device Regulation is expected to come into force in mid-2026, introducing updated classification rules and international reliance routes (leveraging FDA, CE, TGA approvals). All manufacturers — regardless of marking route — must register with MHRA and appoint a UK Responsible Person if based outside the UK.

What is the difference between UKCA and CE marking?

UKCA marking gives access to Great Britain (England, Scotland, Wales), while CE marking gives access to the EU and EEA. UKCA is regulated by the MHRA under UK MDR 2002; CE is regulated under EU MDR 2017/745. UKCA conformity assessments are done by UK Approved Bodies; CE by EU Notified Bodies. UKCA is not recognized in the EU, and CE (after transitional periods) will not be recognized in GB. Northern Ireland requires CE marking — UKCA is not accepted there. Dual UKCA + CE marking is permitted and recommended for manufacturers selling in both markets.

Do I need a UK Responsible Person (UKRP)?

Yes, if your manufacturing business is located outside the UK, you must appoint a UK Responsible Person (UKRP) before you can register your devices with MHRA or place them on the Great Britain market. The UKRP must be legally established in Great Britain and must hold written authority from the manufacturer. The UKRP is responsible for maintaining your MHRA registration, managing DORS submissions, and handling UK vigilance and post-market surveillance reporting. TraccGlobal provides UKRP services through UK-based partner organizations. Contact us at traccglobal.com to discuss UKRP appointment.

Can I use my FDA 510(k) clearance for UKCA?

Currently, FDA 510(k) clearance does not directly support UKCA certification. The UK runs an independent regulatory process under UK MDR 2002. However, the new UK Medical Device Regulation expected in mid-2026 plans to introduce “international reliance routes” that will allow manufacturers to leverage FDA clearances, CE marking, Health Canada licenses, and TGA certifications to expedite UK market access — though this will not provide full UKCA marking. In the meantime, TraccGlobal can use your FDA technical documentation as a starting point for UK MDR 2002 alignment, significantly reducing preparation time.

How long does UKCA certification take?

UKCA certification timelines vary by device class: Class I self-certified (3–6 months for documentation preparation and MHRA registration); Class IIa (6–10 months including UK Approved Body review); Class IIb (8–12 months); Class III (10–18 months due to design dossier examination). These timelines can be longer if technical documentation gaps are identified during review. TraccGlobal’s proactive approach — thorough documentation preparation before Approved Body submission — significantly reduces the chance of non-conformities and delays. Our Class IIb clients have averaged 8-month certification timelines.

What is the MHRA registration fee for UKCA devices in 2026?

From 1 April 2026, MHRA device registration fees are estimated at £300 per GMDN Level 2 category (or Level 1 where no Level 2 exists), paid through DORS via Worldpay or BACS/CHAPS. Approximately 60% of manufacturers are expected to pay only a single charge. These are MHRA registration fees only and are separate from UK Approved Body conformity assessment fees (which vary by body and device complexity) and UKRP service fees. TraccGlobal provides a complete fee estimate before any engagement.

Can Class I medical devices self-certify for UKCA?

Yes. Class I medical devices that are non-sterile and non-measuring can self-certify for UKCA marking without involving a UK Approved Body. The manufacturer must: classify the device correctly, prepare a technical file meeting UK MDR 2002 essential requirements (including a clinical evaluation), sign a UK Declaration of Conformity, affix the UKCA mark, and register with MHRA via DORS. Class I sterile (Is) and Class I measuring (Im) devices do require UK Approved Body involvement for those specific aspects. General IVDs that don’t fall under Annex II Lists A or B also do not require an Approved Body.

Does UKCA marking apply in Northern Ireland?

No. UKCA marking is not valid in Northern Ireland. Under the Windsor Framework, Northern Ireland remains part of the EU Single Market for medical devices. This means devices sold in Northern Ireland must carry the CE mark (or UKNI mark if assessed by a UK-designated Notified Body). Manufacturers selling across the entire UK — both Great Britain and Northern Ireland — must manage dual compliance: UKCA for GB and CE for NI. This is an important distinction for US manufacturers planning UK-wide distribution strategies. TraccGlobal advises on both pathways as part of our UK market entry strategy service.

Ready to Get Your UKCA Mark for Medical Devices?

TraccGlobal’s regulatory experts are ready to review your device, confirm your UKCA classification, and give you a clear timeline and cost estimate — at no charge.